Current Liabilities
Current Debt
Gilead Sciences Current Debt decreased by 53.2% to $1.31B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 53.2%, from $2.81B to $1.31B. Over 5 years (FY 2020 to FY 2025), Current Debt shows relatively stable performance with a 0.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase indicates higher near-term cash outflow requirements, potentially pressuring liquidity.
Detailed definition
This represents the portion of long-term debt obligations that are scheduled to mature and require repayment within the...
Peer comparison
Standard debt metric; peers with high leverage will show higher values here relative to total debt.
Metric ID:
current_portion_long_term_debtHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.26B | $2.51B | $1.52B | $1.03B | $1.02B | $2.27B | $2.27B | $2.28B | $4.04B | $1.79B | $1.8B | $3.67B | $1.81B | $1.81B | $1.82B | $2.81B | $2.81B | $2.81B | $2.81B | $1.31B |
| QoQ Change | — | +11.1% | -39.6% | -32.4% | -0.4% | +122.3% | +0.1% | +0.4% | +76.8% | -55.6% | +0.3% | +103.9% | -50.7% | +0.2% | +0.2% | +54.6% | +0.0% | +0.0% | +0.0% | -53.2% |
| YoY Change | — | — | — | — | -54.8% | -9.6% | +49.9% | +122.7% | +295.4% | -21.0% | -20.9% | +60.6% | -55.2% | +1.1% | +0.9% | -23.5% | +55.1% | +54.9% | +54.7% | -53.2% |
Range$1.02B – $4.04B
CAGR-10.8%
Avg YoY Growth+28.6%
Median YoY Growth+1.0%
Current Debt at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's current debt?
- Gilead Sciences (GILD) reported current debt of $1.31B in Q1 2026.
- How has Gilead Sciences's current debt changed year-over-year?
- Gilead Sciences's current debt decreased by 53.2% year-over-year, from $2.81B to $1.31B.
- What is the long-term trend for Gilead Sciences's current debt?
- Over 5 years (2020 to 2025), Gilead Sciences's current debt has grown at a 0.4% compound annual growth rate (CAGR), from $2.76B to $2.81B.
- What does current debt mean?
- The amount of long-term debt that must be paid back within one year.